The limited demyelinating diseases: the voyage of optic neuritis and transverse myelitis to multiple sclerosis and neuromyelitis


Idiman E., ÖZAKBAŞ S.

EXPERT REVIEW OF NEUROTHERAPEUTICS, vol.11, no.3, pp.451-462, 2011 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Review
  • Volume: 11 Issue: 3
  • Publication Date: 2011
  • Doi Number: 10.1586/ern.11.16
  • Journal Name: EXPERT REVIEW OF NEUROTHERAPEUTICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.451-462
  • Keywords: acute transverse myelitis, aquoporin-4 antibody, multiple sclerosis, neuromyelitis optica, NMO-IgG, NMO spectrum disorders, optic neuritis, opticospinal multiple sclerosis, REVISED DIAGNOSTIC-CRITERIA, ATTACK-RELATED SEVERITY, SPINAL-CORD LESIONS, ANTI-AQUAPORIN-4 ANTIBODY, OLIGOCLONAL BANDS, NATURAL-HISTORY, CLINICAL-COURSE, RISK-FACTORS, BRAIN MRI, FOLLOW-UP
  • Dokuz Eylül University Affiliated: Yes

Abstract

The spectrum of idiopathic inflammatory-demyelinating disorders of the CNS is classified based on clinical symptoms and signs, clinical severity, lesion distribution, neuroimaging features and cerebrospinal fluid characteristics. There is a wide variety of conditions in this broad spectrum. In some cases, the dissemination in the CNS is limited to the optic nerves and spinal cord. Neuromyelitis optica (NMO) and the NMO spectrum disorders have a predilection for the optic nerves and spinal cord. Clinical, MRI, cerebrospinal fluid and neuropathological features show that NMO could be considered as a distinct disease rather than as a variant of multiple sclerosis. Accurate and early diagnosis is critical to facilitate initiation of immunosuppressive and/or immunomodulatory therapy to prevent attacks and disability progression.